Results

Total Results: 685 records

Showing results for "cardiovascular".
Users also searched for: statin

341. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - current wording : “Epidemiologic data suggest that subclinical hypothyroidism is associated with cardiovascular … Omission of data on heart failure is problematic. we feel the term “cardiovascular” includes both, CAD

342. Revised Protocol - Opioids 12 13 13[1] (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
     December 19, 2013 - gastrointestinal-related harms, falls, fractures, motor vehicle accidents, endocrinological harms, infections, cardiovascular … gastrointestinal, falls, fractures, motor vehicle accidents, endocrinological harms, infections, cardiovascular

343. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
     October 05, 2018 - Progestin combination products Multiple* Oral, transdermal, transvaginal Daily 1-3 yr >3 yr Cardiovascular … yr >3 yr Anti-sclerostin monoclonal antibody Romosozumab† SC Monthly 1 yr Not used >1 yr Cardiovascular … 16 CI confidence intervals CKD chronic kidney disease CTX C-terminal telopeptide CVD cardiovascular

344. Dietary Total Fat Intake and Dietary Polyunsaturated Fatty Acid Intake and Child Growth and Development Outcomes: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/child-growth-development-outcomes-protocol.pdf
     August 19, 2024 - Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular … Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular … The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity

345. Vulnerable Atherosclerotic Plaque | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/atherosclerosis-plaque/technical-brief

346. Behavioral Programs for Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/diabetes-behavior-programs_executive.pdf
     September 11, 2015 - diabetes, $9,677 for diagnosed T2DM, and $14,856 for T1DM.11 Complications from diabetes include cardiovascular … participants) of intensive control in T2DM found no significant differences for all-cause mortality or cardiovascular … instance, intensive lowering of blood pressure in people with diabetes has been shown to reduce major cardiovascular … Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative … Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: a systematic review

347. CERs Report cover (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/future05-breastcancer-10-5-2010final.pdf
     September 01, 2010 - Raloxifene effects on breast cancer and cardiovascular events]. … A woman’s heart: the impact of adjuvant endocrine therapy on cardiovascular health. … The international journal of cardiovascular imaging 2009 Apr;25(4):387-396. 288. … /pp, de 97774 8 5 or 6 or 7 414246 9 4 and 8 177 10 exp cardiovascular system/ 355700 11 exp … cardiovascular diseases/ 718165 12 10 or 11 895463 13 exp tamoxifen/ 9988 14 exp raloxifene/ 1818

348. Supplemental Project To Assess the Transparency of Reporting Requirements: Tympanostomy Tubes in Children With Otitis Media (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-tympanostomy_research.pdf
     June 01, 2017 - Search Strategies v Background and Objectives As described in our Omega-3 Fatty Acids and Cardiovascular … Supplemental Project To Assess the Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular … Inclusion criteria: Effects of Omega-3 Fatty Acids on Cardiovascular Disease Appendix C.

349. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - This increases their risk of secondary complications, including cardiovascular disease, nephropathy … This increases their risk of secondary complications, including cardiovascular disease, nephropathy … Metabolic surgery would provide an opportunity for improvement in many cardiovascular risk factors … Standard bariatric surgery has suggested fewer cardiovascular events and possibly fewer cancers in … Reducing cardiovascular risk in patients with type 2 diabetes: Management of dyslipidemia.

350. Future Research Needs Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-cancer-risk-reduction_research.pdf
     October 25, 2010 - Raloxifene effects on breast cancer and cardiovascular events]. … A woman’s heart: the impact of adjuvant endocrine therapy on cardiovascular health. … The international journal of cardiovascular imaging 2009 Apr;25(4):387-396. 288. … /pp, de 97774 8 5 or 6 or 7 414246 9 4 and 8 177 10 exp cardiovascular system/ 355700 11 exp … cardiovascular diseases/ 718165 12 10 or 11 895463 13 exp tamoxifen/ 9988 14 exp raloxifene/ 1818

351. Medication-Adherence-Interventions Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medication-adherence-interventions_executive.pdf
     September 01, 2012 - 100 evaluated the effects of policy-level interventions on medication adherence, specifically for cardiovascular … found statistically significant between-group differences in adherence to medications used to treat cardiovascular … Clinical Condition Intervention Comparator Number of Studies Medication Adherence Other Outcomes Cardiovascular … patients with diabetes to try to help them decide whether to take statins to lower their risk of cardiovascular … Cardiovascular Risk Education and Social Support (CaRESS): report of a randomized controlled trial

352. Updating the Measurement Criteria for AHRQ’s National Healthcare Quality and Disparities Report (NHQDR) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/updating-criteria-qdr-protocol-amendment.pdf
     December 28, 2023 - Quality indicators for acute cardiovascular diseases: a scoping review.

353. Systematic Review on Acute Treatments for Episodic Migraine: Surveillance Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
     June 01, 2022 - Cardiovascular safety of erenumab in patients with migraine with or without a history of aura. … Cardiovascular safety of erenumab in patients with migraine and aura. … Pooled analysis of cardiovascular safety with fremanezumab treatment in patients with migraine by … number of cardiovascular or cerebrovascular risk factors. … Long-term cardiovascular safety of lasmiditan for the acute treatment of migraine for up to one year

354. Management of suspected opioid overdose with Naloxone by Emergency Medical Services personnel (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
     November 29, 2016 - 2015 American Heart Association guideline update for cardiopulmonary resuscitation and emergency cardiovascular … 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular

355. Methods Guide for Medical Test Reviews Chapter 9 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-performance_methods.pdf
     July 01, 2012 - prevalent in two to four percent of middle-aged adults, and has been associated with daytime somnolence, cardiovascular … e.g., with continuous positive airway pressure) reduces symptoms, and, hopefully, long-term risk for cardiovascular

356. Methods Research Report: Linking Evidence Reviews to Organizational Guideline Planning: A Pilot Test of an Interactive Web-Based Presentation and Discussion of Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/linking-evidence-reviews-methods_0.pdf
     October 01, 2018 - At this time, they expressed an interest in cardiovascular-related (including diabetes) topics. … We provided them with a list of 13 recent cardiovascular EPC reports, from which the cardiovascular

357. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-harms_methods.pdf
     November 01, 2008 - published reports of trials evaluating selective or nonselective NSAIDs because an association with cardiovascular … Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit … Risk of cardiovascular events and rofecoxib: cumulative meta- analysis.

358. Research White Paper - Assessing the Predictive Validity of Strength of Evidence Grades: A Meta-Epidemiological Study (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
     September 01, 2015 - congestive heart failure 10,281 RR: 5.11 (3 to 8.72) Musini Vijaya et al., 200935 Pharmacotherapy and cardiovascular … Hormone therapy for preventing cardiovascular disease in post-menopausal women. … treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular

359. UBIQUS Document (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/oct_13_webinar_transript_10-13-11.pdf
     October 13, 2011 - He also serves as a consumer stakeholder on AHRQs DEcIDE Cardiovascular Consortium, and has previously … disseminate important information to patients and consumers, caregivers, clinicians, and educators on cardiovascular … It combines many little changes that have big impacts on cardiovascular health.

360. 8 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_chou_assessing_harms_when_comparing.pdf
     November 01, 2008 - published reports of trials evaluating selective or nonselective NSAIDs because an association with cardiovascular … Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit … Risk of cardiovascular events and rofecoxib: cumulative meta- analysis.